Cofrogliptin or linagliptin added to insulin for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests if adding either cofrogliptin or linagliptin (two pills that help control blood sugar) to your current insulin treatment can improve diabetes control. It is for adults with type 2 diabetes whose blood sugar is still not well managed with insulin and certain other diabetes pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have been diagnosed with type 2 diabetes.
- Your recent A1C (average blood sugar over 2-3 months) is between 7% and 9%, and your fasting blood sugar is 11 mmol/L or lower.
- You have been on a stable insulin regimen (basal once daily or weekly, premixed once or twice daily, or a specific insulin called IDegAsp once or twice daily) for at least 12 weeks. You may also be taking up to three other diabetes pills, but only metformin, SGLT2 inhibitors, or alpha-glucosidase inhibitors.
- You have already decided with your doctor to start cofrogliptin or linagliptin, and you start it within 2 weeks before or 2 weeks after signing this consent form.
- You are not allergic to the study drugs, do not have type 1 diabetes, and are not pregnant or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This trial tests a new pill called cofrogliptin against a standard medicine called acarbose to see which better controls blood sugar in people with type 2 diabetes who have never taken diabetes medication. It's for those managing their diabetes with diet and exercise alone.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
This study tests whether an oral medication called Cofrogliptin can help your pancreas make more insulin. It's for adults with LADA who still produce some of their own insulin and do not need daily insulin right away.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.